(2(2(4-ME-4H-(1,2,4)TRIAZOL-3-YLSULFANYL)-ACETYLAMINO)-THIAZOL-4-YL)-ACETIC ACID

(22E)-11-OXO-5-ALPHA,14-BETA-ERGOSTA-8,22-DIEN-3-BETA-YL ACETATE

(22E)-5-ALPHA-ERGOSTA-7,9(11),22-TRIEN-3-BETA-YL ACETATE

(22E)-5-HYDROXY-11-OXO-5-ALPHA-ERGOSTA-7,22-DIEN-3-BETA-YL ACETATE

(22E)-7-ALPHA,8-EPOXY-5-ALPHA,8-ALPHA-ERGOST-22-EN-3-BETA-YL ACETATE

(22E)-ERGOSTA-5,7,22-TRIEN-3-BETA-YL ACETATE

(2alpha,5alpha,17beta)-2-[(dimethylamino)methyl]-17-hydroxy-17-methylandrostan-3-one

(2E,4E)-6-METHYL-2,4-HEPTADIEN-1-OL

(2E)-1-(4-Methoxyphenyl)-2-buten-1-one

(2E)-2-[3-METHOXY-4-(PENTYLOXY)BENZYLIDENE]-6-PHENYL-7H-[1,3]THIAZOLO[3,2-B][1,2,4]TRIAZINE-3,7(2H)-DIONE

(2E)-2-(4-chlorophenyl)-3-(4-methylphenyl)-2-propenoic acid

(2E)-2-(BENZOYLHYDRAZONO)-4-[2-(2-CHLOROANILINO)-4-METHYL-1,3-THIAZOL-5-YL]-N-(4-ETHOXYPHENYL)-4-OXOBUTANAMIDE

(2E)-2-BUTENEDIOIC ACID COMPOUND WITH N-[2-(2-CHLOROPHENYL)-1,1-DIMETHYL-2-OXOETHYL]-N-METHYL-2-(1-PIPERIDINYL)ACETAMIDE

(2E)-3-[4-(Benzyloxy)-3-ethoxyphenyl]-2-propenoic acid

(2E)-3-(2-Nitrophenyl)-2-phenyl-2-propenoic acid